get a key
steadybase-$ company MLYS
account_id none on file
legal_name Mineralys Therapeutics, Inc.
ticker MLYS
cik 1933414
domain mineralystx.com
entry_point_account_id none on file
name Mineralys Therapeutics Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 46 executives 0 family 0
why_nownone on file
callsnone on file
filings
Senior Vice President, Regulatory Affairs | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5422451008", "remote": true, "category": "other", "function": "executive", "location": "US Rem

company_statement / Sep 11, 2026 / receipt

Sr. Digital Product Manager | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5418109008", "remote": true, "category": "other", "function": "product", "location": "US Remote", "job_title

company_statement / Sep 10, 2026 / receipt

Manager, Travel & Expense Operations | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5392611008", "remote": true, "category": "travel_admin", "function": "travel_te", "location": "US R

company_statement / Aug 20, 2026 / receipt

Senior Accountant - Corporate Accounting | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5393906008", "remote": true, "category": "other", "function": "finance", "location": "US Remote

company_statement / Aug 20, 2026 / receipt

Director, Sales Capability & Performance Development | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5395452008", "remote": true, "category": "sales_expansion", "function": "sales", "l

company_statement / Aug 19, 2026 / receipt

Director, Sales Training & Field Enablement | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5395468008", "remote": true, "category": "sales_expansion", "function": "sales", "location":

company_statement / Aug 19, 2026 / receipt

Senior Director, Scientific Communications & Medical Communications | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5386697008", "remote": true, "category": "other", "function": "marke

company_statement / Aug 11, 2026 / receipt

Hypertension + CKD

ir_statement / Aug 8, 2026 / receipt

Hypertension + OSA

ir_statement / Aug 8, 2026 / receipt

Market Expansion Proof-of-Concept Trials

ir_statement / Aug 8, 2026 / receipt

any delays in the FDA’s review of our accepted NDA, including as a result of a government shutdown or reductions in agency funding or personnel

ir_statement / Aug 8, 2026 / receipt

macroeconomic trends and uncertainty with regard to high interest rates, elevated inflation, tariffs and other trade policies, and the potential for a local and/or global economic recession

ir_statement / Aug 8, 2026 / receipt

executivesnone on file
familynone on file
upcoming
2026-11-09 earnings call scheduled ir
changesnone on file
mcp_package_hint
steadybase-$